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Environmental tobacco smoke (ETS) is an 
environmental trigger that leads to airway 
inflammation and asthma symptoms in sus-
ceptible individuals and animals (Martinez 
2003; Weiss 1994, 1999). Exposure to ETS 
in utero or during early post  natal develop  ment 
increases the incidence of respiratory illnesses 
(Gilliland et al. 2002; Haberg et al. 2007; Li 
et al. 2005; Martinez et al. 1992; Raherison 
et al. 2007; Wang et al. 2008; Weitzman et al. 
1990) and airway hyper  reactivity (Frischer 
et al. 1992; Skorge et al. 2005; Tager et al. 
1983) later in life. The nervous system, 
including the nerves supplying the airways, is 
highly susceptible to environmental influences 
during develop  ment. Epidemiologic studies 
show that the probability of developing or 
exacerbating childhood asthma is increased 
in children of mothers who smoke cigarettes 
(Gilliland et al. 2002; Haberg et al. 2007; Li 
et al. 2005; Martinez et al. 1992; Raherison 
et al. 2007; Wang et al. 2008; Weitzman 
et al. 1990). These results suggest a possible 
critical period of developmental sensitivity to 
cigarette smoke exposure during the prenatal 
and early postnatal period.
Airway innervation develops rapidly dur-
ing fetal and early postnatal life, in parallel 
with the development of the lungs (Dey and 
Hung 1998). Given the dynamic and vul-
nerable nature of developmental processes, 
this period of morpho  genesis is likely to be 
exquisitely sensitive to environmental insults 
(Dietert et al. 2000; Pinkerton and Joad 
2000). Substance P (SP), a neuropeptide and 
member of the tachy  kinin family, has potent 
effects on airway smooth muscle tone, vascular 
permeability, and mucus secretion (Barnes 
et al. 1991; Lundberg et al. 1983b, 1984). SP 
plays an important role in antigen- or irritant-
induced airway hyper  responsiveness (AHR) 
and asthma (Ollerenshaw et al. 1991; Wu and 
Lee 1999; Wu et al. 1997, 2000, 2001). Our 
research has demon  strated that increased SP 
levels in the airway are involved in cigarette-
smoke exposure–enhanced airway constriction 
to methacholine (MCh) (Wu and Lee 1999).
Nerve growth factor (NGF) is a neuro-
trophic factor that promotes and maintains 
growth and survival of the central and periph-
eral nervous system (Levi-Montalcini 1987). 
NGF in the lung increases during gestation 
and decreases progressively with postnatal age 
(Hu et al. 2002). Disruption of normal syn-
thesis and release of NGF results in changes in 
airway innervation that lead to disease-related 
abnormalities in the respiratory system (Hu 
et al. 2002; Tortorolo et al 2005; Wilfong and 
Dey 2004, 2005). Our recent studies have 
shown that NGF is produced in response to 
irritant exposures and mediates changes in the 
phenotype and distribution of SP-containing 
neurons in the airways (Wilfong and Dey 
2004, 2005).
Thus, we hypothesized that susceptibil-
ity to ETS exposure exists during prenatal 
and early postnatal periods, and that ETS 
exposure during these “critical periods” would 
alter SP airway innervation, possibly through 
an NGF-mediated mechanism, increas-
ing susceptibility to AHR in later life. We 
designed the present experiments to identify 
critical developmental periods of susceptibil-
ity to sidestream smoke (SS; a surrogate for 
ETS exposure) in mice and to characterize 
changes in SP innervation and NGF expres-
sion during critical periods of developmental 
susceptibility to SS.
Materials and Methods
ICR mice (Harlan, Indianapolis, IN) were 
housed with ad libitum access to food and 
water in a facility approved by the U.S. Food 
and Drug Administration. All procedures were 
performed in accordance with the Guide for the 
Care and Use of Laboratory Animals (Institute 
of Laboratory Animal Resources 1996), and 
the protocols were approved by the West 
Virginia University Animal Care and Use 
Committee (protocol 06-0501). The animals 
were treated humanely and with regard for 
alleviation of suffering.
SS exposure. We investigated the effects 
of SS exposure in three different ages of mice: 
gestation days (GDs) 7–16, which corresponds 
to the period of human fetal lung develop-
ment; post  natal days (PNDs) 2–11, which 
corresponds to the human neonatal period; 
and PNDs 21–30, which is similar to the 
human prepubertal time period (Pinkerton 
and Joad 2000; Wang and Pinkerton 2008). 
Tobacco smoke exposure in monkey, rat, or 
mouse models has shown that ETS exposure 
Address correspondence to Z.-X. Wu, Department 
of Neurobiology and Anatomy, P.O. Box 9128, 
Robert C. Byrd Health Sciences Center, West 
Virginia University, Morgantown, WV 26506 USA. 
Telephone: (304) 293-7222. Fax: (304) 293-8159. 
E-mail: zwu@hsc.wvu.edu
We thank C. Dong (Department of Statistics, 
West Virginia University) for statistical analysis.
This study was supported by grants R01 HL35812 
and HL080566 from the National Institutes of 
Health, and grant R03 ES014618 from the National 
Institute of Environmental Health Sciences.
The authors declare they have no competing 
  financial interests.
Received 19 December 2008; accepted 22 May 2009.
Prenatal and Early, but Not Late, Postnatal Exposure of Mice to Sidestream 
Tobacco Smoke Increases Airway Hyperresponsiveness Later in Life
Zhong-Xin Wu,1 Dawn D. Hunter,1 Vincent L. Kish,2 Katherine M. Benders,1 Thomas P. Batchelor,1 and 
Richard D. Dey1
1Department of Neurobiology and Anatomy, and 2Department of Orthopedics, Robert C. Byrd Health Sciences Center, West Virginia 
University, Morgantown, West Virginia, USA
Ba c k g r o u n d: Cigarette smoke exposure in utero and during early postnatal development increases 
the incidence of asthma and airway hyperresponsiveness (AHR) later in life, suggesting that a pos-
sible critical period of developmental sensitivity exists in the prenatal and early postnatal periods.
oB j e c t i v e: We investigated mechanisms of susceptibility during critical developmental periods to 
sidestream smoke (SS) exposure and evaluated the possible effects of SS on neural responses.
Me t h o d s : We exposed three different age groups of mice to either SS or filtered air (FA) for 
10 consecutive days beginning on gestation day (GD) 7 by maternal exposure or beginning on 
postnatal day (PND) 2 or PND21 by direct inhalation. Lung function, airway substance P (SP) 
innervation, and nerve growth factor (NGF) levels in broncho  alveolar lavage fluid were measured 
after a single SS exposure on PND59.
re s u l t s: Methacholine (MCh) dose response for lung resistance (RL) was significantly elevated, and 
dynamic pulmonary compliance (Cdyn) was significantly decreased, in the GD7 and PND2 SS expo-
sure groups compared with the FA groups after SS exposure on PND59. At the same time points, 
the percent area of SP nerve fibers in tracheal smooth muscle and the levels of NGF were signifi-
cantly elevated. MCh dose–response curves for RL and Cdyn, SP nerve fiber density, and the level of 
NGF were not significantly changed in the PND21 exposure group after SS exposure on PND59.
co n c l u s i o n s: These results suggest that a critical period of susceptibility to SS exposure exists in the 
prenatal and early postnatal period of development in mice that results in increased SP innervation, 
increased NGF levels in the airway, and enhanced MCh AHR later in life.
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for 6 hr/day for a few weeks to 2 months alters 
pulmonary function and immune responses 
(Barrett et al. 2002; Ji et al. 1998; Joad et al. 
1995; Yu et al. 2008). We exposed mice in 
each age group to either SS or filtered air (FA) 
for 6 hr/day for 10 consecutive days begin-
ning on GD7 (by maternal exposure) or on 
PND2 or PND21 (direct exposure; Figure 1). 
The 10-day exposure periods were chosen to 
allow testing of our experimental design in 
non  overlapping developmental time periods. 
In addition, by 2 weeks of age, mouse lungs 
and the pulmonary nervous systems are near-
ing maturity; thus, exposure in the PND2 
group was completed before lung maturity and 
exposure in the PND21 began after maturity. 
For the GD7 group, exposure began 10 days 
before the approximate date of parturition, 
during the period when lung buds are begin-
ning to form and nerves begin to invade the 
lung (Tollet et al. 2002).
Pulmonary function testing was measured 
before or 16 hr after a 6-hr exposure to SS on 
PND59 (Figure 1). The intent of this design 
was to examine plasticity of airway responsive-
ness and potential mechanisms associated with 
early-life exposure by comparing responsiveness 
to an irritant exposure (SS) after a period of 
recovery in naive mice and mice exposed to SS 
at three stages of early life. Because we found 
that pulmonary function was altered only after 
exposure to SS on PND59 (Figures 2 and 3), 
SP nerve fiber density (NFD) and NGF and 
inflammatory cells in bronchoalveolar lavage 
fluid (BALF) were measured only after the 
PND59 exposure.
By classical definition, ETS is a diluted 
mixture of the smoke given off by the burning 
end of a tobacco product (SS, ~ 85%) and the 
smoke exhaled by smokers (mainstream smoke, 
~ 15%). Base on previous ETS exposure stud-
ies (Pinkerton and Joad 2000; Yu et al. 2008), 
we used SS as a surrogate for ETS. The SS 
exposure protocol in this study used the same 
exposure equipment and followed the meth-
ods described previously (Porter et al. 2007). 
Briefly, randomly chosen mice were placed 
in a BioClean exposure chamber (DuoFlo, 
model H 5500; Lab Products Inc., Maywood 
NJ) that measured 1.92 × 1.92 × 0.97 m 
(3.58 m3). The mice were housed in separate 
cages located inside the exposure chamber. SS 
from Marlboro filter cigarettes (Phillip Morris, 
Richmond, VA) was introduced into the 
exposure chamber at a rate of four cigarettes 
every 15 min for 6 hr/day for 10 days using a 
smoking machine (RM 1/G; Heinr Borgwald 
GmbH, Hamburg, Germany). At the end of 
the 6-hr exposure period, the exhaust fan on 
the BioClean unit was turned on to rapidly 
lower the level of SS in the exposure chamber. 
The mice were then transported to the animal 
facilities, where they remained overnight, until 
the next day’s exposure. The concentrations 
of carbon monoxide in the exposure cham-
ber were monitored and kept to an average of 
about 50 ppm; relative humidity was about 
50%, and temperature was approximately 
23°C. Total suspended particulate concentra-
tion was approximately 1.1 mg/m3, similar 
to exposure levels used by others to approxi-
mate the cloud of particulates surrounding 
a person during active smoking (Yu et al. 
2008). The level of nicotine in blood was also 
measured immediately after 1 week of SS or 
FA exposure. Briefly, blood was drawn from 
the orbital plexus of each mouse (eight mice 
for SS and eight mice for FA) and allowed 
to clot at room temperature for 30–45 min. 
The resulting serum was stored at –80°C and 
was assessed by an independent laboratory 
(National Medical Services, Willow Grove, 
PA) using gas   chromatography.
Measurements of lung function. We deter-
mined lung function by measuring changes of 
pulmonary resistance (RL) and dynamic com-
pliance (Cdyn) after aerosolized MCh chal-
lenge using a modification of our previously 
described technique (Kwong et al. 2001; Wu 
and Lee 1999; Wu et al. 1997, 2000). Briefly, 
mice were anesthetized with pentobarbital 
(70 mg/kg, intraperitoneally) before or 16 hr 
after exposure to SS or FA on PND59. The 
trachea was cannulated just below the larynx 
via a tracheotomy, and a four-way connec-
tor was attached to the tracheotomy tube. 
Two ports were connected to the inspiratory 
and expiratory tubes of a respirator (model 
845; Harvard Instruments, Holliston, MA). 
The mice were ventilated at a constant rate 
of 200 breaths/min and a tidal volume of 
approximately 0.2 mL. Aerosolized MCh 
chloride (Sigma, St. Louis, MO) was admin-
istered for 10 sec in increasing concentrations 
(0, 6.25, 12.5, 25, and 50 mg/mL). For 5 min 
before and after each MCh challenge, total RL 
and Cdyn were analyzed by computer on a 
breath-by-breath basis.
Inflammatory cell analysis in BALF. We 
obtained BALF by injecting and withdrawing 
1 mL of sterile saline three times (3 mL total) 
via the tracheal cannula 16 hr after exposure to 
SS on PND59. The collected BALF (~ 2.5 mL) 
was centrifuged at 1,500 rpm for 10 min. The 
supernatant was frozen at –80°C for NGF 
assays, and the pelleted cells were treated with 
Tris-buffered ammonium chloride solution 
(pH 7.2) to lyse red blood cells. The remain-
ing cells were washed once with phosphate-
buffered saline (PBS) supplemented with 1% 
fetal calf serum, 100 U/mL penicillin, 100 µg/
mL streptomycin, and 250 ng/mL amphot-
ericin (Gibco Brl, Grand Island, NY). Total 
cell counts were determined using a hemo-
cytometer. Differential leukocyte counts were 
then performed on cytospin slides. A mini-
mum of 200 leukocytes and macrophages were 
counted using standard morphologic criteria.
NGF enzyme-linked immunosorbent assay 
(ELISA). We conducted the NGF ELISA 
as previously described by Wilfong and 
Dey (2004, 2005). Briefly, the BALF super-
natants collected 16 hr after exposure to SS on 
PND59 were frozen at –80°C until assayed. 
The concentration of NGF (7.8–500 pg/mL) 
in each sample was assayed using the NGF 
Emax ImmunoAssay System (Promega, 
Madison, WI) according to the manufactur-
er’s instructions. NGF was detected using an 
antibody sandwich format in 96-well plates. 
Each well was initially coated with 100 µL of 
anti-NGF antibody and incubated overnight, 
followed by a 1-hr incubation with blocking 
buffer (200 µL/well) to prevent non  specific 
binding. Either 100 µL lavage supernatant 
or 100 µL NGF standard (7.8–500 pg/mL) 
Figure 1. Time line for SS exposure and experimental measurement. Prenatal exposures occurred between 
GD7 and GD16; early postnatal exposure occurred PNDs 2–11; late postnatal exposure occurred PNDs 
21–30. All groups were exposed to SS on PND59. Pulmonary function testing was conducted immediately 
before and 16 hr after reexposure. Samples for all other evaluations (bronchoalveolar lavage and airway 
removal for immunocytochemistry) were collected 16 hr after exposure.
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was then added to each well. The plate was 
incubated for 6 hr, followed by an overnight 
incubation with anti-NGF monoclonal anti-
body (100 µL/well). For color develop  ment, an 
anti-rat IgG-horseradish peroxidase–conjugated 
antibody was added to each well (100 µL), fol-
lowed by a tetramethly  benzidine solution that 
reacted with the peroxidase-labeled conjugates 
to develop a blue color. The absorbance of each 
well was measured at 450 nm on a Spectra 
Max 340pc plate reader (Molecular Devices, 
Sunnyvale, CA). The concentration of NGF 
in each lavage sample was determined from the 
NGF standard curve. All samples were run in 
duplicate or triplicate, and a PBS sample was 
run with each assay as a negative control.
Immunocytochemistry. The procedures   
for immunocytochemical demonstration of 
SP-like immunoreactivity have been described 
previously (Dey et al. 1999; Wu et al. 2002, 
2004). Briefly, tracheal segments were removed 
16 hr after exposure to SS on PND59, fixed in 
picric acid/formaldehyde fixa  tive for 3 hr, and 
then rinsed three times with 0.1 M PBS con-
taining 0.3% Triton X-100 (PBS-TX), frozen 
in iso  pentane, cooled with liquid nitrogen, 
and stored at –80°C. Cryostat sections (12 µm 
thickness) were collected on gelatin-coated 
cover slips and dried briefly at room tempera-
ture. Sections were covered with SP antibody 
(diluted 1:200; Peninsula Inc., Belmont, 
CA), incubated at 4°C for 24 min, rinsed 
three times with a 1% bovine serum albumin/
PBS-TX solution, covered with fluorescein 
isothiocyanate–labeled goat anti-rabbit anti-
body (diluted 1:100; ICN Immunobiologicals, 
Costa Mesa, CA), incubated at 37°C for 
30 min, and rinsed. After all immuno    cyto-
chemical procedures were conducted, the 
cover slips were mounted with Fluoromount 
and observed with a fluorescence microscope.
For measuring NFD in tracheal smooth 
muscle, we collected images of SP-containing 
nerve fibers in series with a Zeiss LSM 510 
confocal microscope (Carl Zeiss MicroImaging 
GmbH, Göttingen, Germany). A series of 
images representing all of the tracheal smooth 
muscle in a section were collected in digital 
files, saved to an internal database, and meas-
ured digitally with Optimas software (Media 
Cybernetics Inc., Bethesda, MD). The smooth 
muscle regions were outlined to measure 
total cross-sectional area of smooth muscle. 
SP-positive nerve fibers were identified by seg-
mentation using threshold gray levels with the 
Optimas software. NFD was then calculated 
as percentage of SP-immunoreactive nerve 
fiber area based on the total cross-sectional 
area of smooth muscle. At least 10 measure-
ments were made for each section, and eight 
sections were measured in each animal.
Data analysis. Unless otherwise stated, 
results are expressed as mean ± SE. Values for 
RL and Cdyn elicited by MCh are expressed as 
a percentage of the baseline. NFD is expressed 
as percent area of SP-immunoreactive nerve 
fibers in the total area of the smooth muscle. 
Statistical analyses of lung function, inflam-
matory cell, and NGF release in BALF were 
performed using one-way or two-way analysis 
of variance. A p-value < 0.05 was considered 
significant, and n represents the number of 
animals studied.
Results
Effect of SS during prenatal or postnatal 
period on the changes of lung function. The 
average nicotine concentration in serum was 
about 0 ng/mL after FA exposure; nico  tine 
measured in the SS-exposed animals at the 
Figure 2. MCh dose responses of RL and Cdyn in GD7 (A and D), PND2 (B and E), and PND21 (C and F) FA- or 
SS-exposed mice before SS exposure on PND59. Data are mean ± SE of 6 mice/group.
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Figure 3. MCh dose responses of RL and Cdyn in GD7 (A and D), PND2 (B and E), and PND21 (C and F) FA- or 
SS-exposed mice after SS exposure on PND59. Data are mean ± SE of six mice/group. 
*Significant difference in corresponding data between FA and SS animals (p ≤ 0.05).
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end of the SS exposure was approximately 
20 ng/mL [95% confidence interval (CI), 
15.5–24.5; n = 8], which is similar to nico-
tine levels typically found in human smokers 
(10–50 ng/mL) (Benowitz and Jacob 1984; 
World Health Organization 2003).
The baseline RL and Cdyn values in the 
different groups were not significantly differ-
ent before MCh challenge (Table 1). Before 
SS exposure on PND59, we found no signifi-
cant difference in the RL and Cdyn responses 
to MCh challenge between mice exposed to 
FA or SS in any of the three time periods 
(GD7, PND2, PND21; Figure 2). However, 
after SS exposure on PND59, the MCh dose–
response curves were significantly elevated 
for RL and significantly decreased for Cdyn 
in mice exposed to SS versus FA beginning 
on GD7 or on PND2 (Figure 3). For exam-
ple, a 50 mg/mL MCh dose increased RL 
by 296% (95% CI, 222–370%) in the GD7 
FA exposure group and by 544% (95% CI, 
410–678%) in the GD7 SS exposure group 
(Figure 3). At the same time, 50 mg/mL MCh 
increased RL by 315% (95% CI, 233–397%) 
in the PND2 FA exposure group and by 
510% (95% CI, 402–618%) in the PND2 SS 
exposure group. The significant differences in 
the Cdyn response to MCh between SS- and 
FA-exposed mice were in the GD7 and PND2 
exposure groups (95% CI, –90 to –62% vs. 
–57 to –35% and –84 to –60% vs. –54 to 
–42%, respectively). However, we found no 
significant difference in RL or Cdyn responses 
to MCh between the PND21 FA- and 
SS-exposed groups. The same MCh dose pro-
duced a 320% (95% CI, 246–394%) increase 
in RL in the PND21 FA exposure group and 
385% (95% CI, 301–471%) increase in the 
PND21 SS exposure group.
Effect of SS during prenatal or post  natal 
period on changes of SP-immunoreactive 
NFD in tracheal smooth muscle. The per-
cent area of SP-immunoreactive nerve fibers 
in tracheal smooth muscle was significantly 
different between FA- and SS-exposed mice 
in the GD7 and PND2 exposure groups. 
SP NFD in trachea was significantly increased 
in GD7 and PND2 exposure groups 16 hr 
after exposure to SS on PND59 (95% CIs, 
0.04–0.105% and 0.034–0.078%, respec-
tively, for FA-exposed mice; 0.08–0.2% and 
0.09–0.19%, respectively, for SS-exposed 
mice) (Figures 4 and 5). At the same time, 
SP NFD did not change significantly 
in FA- and SS-exposed mice in PND21 
groups, increasing only from 0.04–0.10% 
in PND21 FA-exposed mice to 0.06–0.12% 
in SS-exposed mice (Figures 4 and 5). These 
findings suggest that the initial exposure to SS 
during prenatal or early postnatal periods sig-
nificantly enhance the levels of SP innervation 
in tracheal smooth muscle after SS exposure 
at PND59. However, the changes in SP NFD 
did not occur in SS- and FA-exposed mice in 
the PND21 group.
Table 1. The baseline of RL (cm H2O/mL/sec) and Cdyn (mL/cm H2O) in different groups. 
Before SS exposure on PND59  After SS exposure on PND59
Group RL Cdyn  RL  Cdyn
GD7 SS 1.12 ± 0.11 0.053 ± 0.014 1.18 ± 0.19 0.046 ± 0.016
GD7 FA 1.04 ± 0.13 0.058 ± 0.016 1.11 ± 0.11 0.054 ± 0.017
PND2 SS 1.01 ± 0.09 0.065 ± 0.011 1.09 ± 0.13 0.053 ± 0.012
PND2 FA 0.94 ± 0.12 0.069 ± 0.016 1.03 ± 0.15 0.059 ± 0.007
PND21 SS 1.08 ± 0.05 0.062 ± 0.008 1.02 ± 0.10 0.069 ± 0.011
PND21 FA 1.01 ± 0.08 0.067 ± 0.007 0.96 ± 0.12 0.072 ± 0.014
Data are mean ± SE of 6 mice/group.
Figure 4. Fluorescence photomicrographs of SP-immunoreactive NFD within tracheal smooth muscle in 
GD7 FA- (A) or SS-exposed (B), PND2 FA- (C) or SS-exposed (D), and PND21 FA- (E) or SS-exposed (F) 
mice after SS exposure on PND59. (A, C, and E) FA exposure in GD7, PND2, and PND21 groups: nega-
tive SP immunoreactivity in tracheal smooth muscle. (B and D) SS exposure in GD7 and PND2 groups: 
increased SP-immunoreactive nerve fibers in tracheal smooth muscle. (F) SS exposure in PND21: few 
SP-immunoreactive nerve fibers are present in tracheal smooth muscle.
FA
GD7
PND2
PND21
SS
Figure 5. Changes of SP NFD in tracheal smooth 
muscle in GD7 (A), PND2 (B), and PND21 (C) FA- or 
SS-exposed mice after SS exposure on PND59. 
Data are mean ± SE of 8/group.
*Significant difference between FA- and SS-exposed mice 
(p ≤ 0.05).
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Assessments of airway inflammation and 
NGF release from BALF. The total cells in the 
BALF were not markedly different between 
FA- and SS-exposed mice in the GD7 and 
PND2 exposure groups. However, the per-
centages of neutrophils were signifi  cantly 
higher in SS- versus FA-exposed mice in the 
GD7 (18.2% vs. 7.01%) and PND2 (17.84% 
vs. 8.27%) groups 16 hr after SS exposure on 
PND59 (Table 2). The percentage of neutro-
phils was not significantly different in SS- 
and FA-exposed mice in the PND21 group 
(12.84% vs. 8.27%; Table 2).
The concentrations of NGF in BALF were 
significantly higher in SS- versus FA-exposed 
mice in the GD7 and PND2 exposure groups 
16 hr after SS exposure on PND59 (95% CI, 
167–375 vs. 23–143 pg/mL and 214–450 
vs. 58–180 pg/mL, respectively). At the same 
time, the level of NGF was not significantly 
different in SS versus FA mice in the PND21 
group (95% CI, 70–234 vs. 24–166 pg/mL; 
Figure 6).
Discussion
ETS exposure in infants and children increases 
respiratory symptoms such as coughs (Dodge 
1982; Ekwo et al. 1983), wheezing (Dodge 
1982), and airway obstruction (Sherrill et al. 
1992; Wang et al. 1994). Maternal smoking 
during pregnancy also affects lung function 
in early life (Brown et al. 1995; Tager et al. 
1995). Epidemiologic studies show that chil-
dren are more susceptible to adverse respira-
tory effects of passive smoking than are adults 
(Lebowitz et al. 1992), suggesting that expo-
sure to ETS in early development may be a 
predisposing factor for such conditions. The 
results obtained from the present study show 
that lung function and SP innervation in tra-
cheal smooth muscle after exposure to SS on 
PND59 were significantly different and that 
the level of NGF in BALF was significantly 
elevated in mice initially exposed to SS versus 
FA during early periods of development (pre-
natal and early postnatal period). However, 
initial exposure to SS during a later period 
of develop  ment (PND21) did not appear to 
affect lung function or SP innervation of the 
airways after SS exposure on PND59, sug-
gesting that a critical period of susceptibil-
ity exists during prenatal and early postnatal 
periods. The data also indicate that increased 
SP innervation is associated with elevated NGF 
levels in airways.
Some studies have shown that children 
exposed to smoke in early life have both imme-
diate and persistent detrimental effects on lung 
health (Burchfiel et al. 1986; Chilmonczyk 
et al. 1993; Frischer et al. 1992; Martinez et al. 
1992; Morgan and Martinez 1992; Ronchetti 
et al. 1992; Singh et al. 2003; Skorge et al. 
2005; Tager et al. 1983; Weitzman et al. 
1990). However, most of these studies focus 
on immune mechanisms that contribute to 
the development of airway diseases. Airway 
sensitivity and airway responsiveness change 
with age (Aberg and Alder 1973; Clerici et al. 
1989; Duncan and Douglas 1985; Sparrow 
and Mitchell 1990). Innervation of the air-
ways and lungs is not fully developed in the 
early postnatal stage of life. The sensitivity of 
airway nerves in newborns is higher than in 
adults (Larsen et al. 2004). Interestingly, the 
distribution and density of peptidergic nerves 
in young children are lower than in adults 
(Hislop et al. 1990). Thus, neuro  transmitter 
expression is age related, which suggests the 
possibility that SS exposure during periods of 
rapid lung growth and remodeling may alter 
the normal developmental process. SP is local-
ized within cell bodies of sensory neurons that 
project their peripheral axons to the respira-
tory system, innervating mucosal blood vessels, 
mucous glands, airway smooth muscle, and 
epithelium (Dey et al. 1990; Lee et al. 1985; 
Lundberg et al. 1983b, 1984). SP acts as a 
neuro  modulator, increasing cholinergic sensi-
tivity of airway smooth muscle (Cheung et al. 
1994) and increasing the excitability of air-
way neurons (Myers et al. 1990). Transient 
increases in SP in sensory cell bodies projecting 
to the airways and in axons innervating the air-
way wall have been observed after irritant expo-
sures (Graham et al. 2001; Hunter et al. 2000; 
Lundberg et al. 1983a; Wilfong and Dey 2004, 
2005). Our findings in the present study, that 
an initial exposure to SS during prenatal and 
early postnatal periods in mice was associated 
with significantly decreased lung function and 
increased SP NFD in tracheal smooth muscle 
after exposure to SS on PND59, indicate that 
SP could modulate the pathogenesis of AHR 
later in life. A recent study found that ETS 
exposure during early life enhanced SP nerves 
in bronchial epithelium in infant monkeys, 
accompanied by inflammatory changes in the 
lung (Yu et al. 2008). Several studies have 
found that increased SP synthesis is involved 
in the pathogenesis of human airway dis-
eases. Ollerenshaw et al. (1991) demonstrated 
increased SP NFD in airway smooth muscle 
of severe asthmatics. SP NFD was increased in 
airway epithelium from human subjects with 
persistent non  productive cough (O’Connell 
et al. 1996). These studies show that enhanced 
SP innervation in human airway sensory nerves 
may contribute to altered airway function.
Neurotrophins, such as NGF, are essential 
in promoting and maintaining differentiation, 
growth, and survival of cells of the central and 
peripheral nervous systems, including those 
that innervate the airways (Leon et al. 1994; 
Levi-Montalcini 1987). Disruption of normal 
synthesis and release of neuro  trophic factors 
changes airway innervation after inhalation 
of toxic material in adult lungs and leads to 
disease-related abnormalities in the respiratory 
system (Hu et al. 2002). Our recent studies 
found that exposure to toluene diiso  cyanate, 
a known airway irritant, directly enhances the 
level of NGF in airway (Wilfong and Dey 
2004, 2005). We designed the present study 
to address the hypothesis that increased NGF 
after SS exposure enhances SP innervation in 
airways. Our data show that levels of NGF in 
BALF and SP innervation were both elevated 
in animals exposed to SS during prenatal or 
early post  natal periods, suggesting that NGF 
enhances SP innervation. We reported previ-
ously that NGF was involved in mediating 
increased SP expression in ferret airways after 
ozone exposure (Wu and Dey 2006), support-
ing the possibility that NGF serves as a signal-
ing molecule during inflammatory events in 
the airways by regulating sensory neuropeptide 
production. Because NGF also stimulates neu-
ronal growth, enhanced SP innervation of the 
airway wall may also occur in axon sprouting. 
Therefore, SS-enhanced NGF production in 
lung may produce increased SP levels in the 
airway both by increasing SP expression and 
by increasing the branching of SP-containing 
Figure 6. Levels of NGF release in BALF in GD7 (A), 
PND2 (B), and PND21 (C) FA- or SS-exposed mice 
after SS exposure on PND59. Data are mean ± SE 
of 6/group. NGF was measured by ELISA. 
*Significant difference between FA- and SS-exposed mice 
(p ≤ 0.05).
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Table 2. Effect of SS or FA exposure at GD7, PND2, and PND21 mice after SS exposure on PND59 on leuko-
cyte counts in BALF. 
Group Total cells (×105) Neutrophils (%) Eosinophils (%) Lymphocytes (%) Macrophages (%)
GD7 SS (n = 6) 39.32 ± 8.54 18.20 ± 3.61* 4.55 ± 1.83 5.62 ± 2.87 71.63 ± 7.92
GD7 FA (n = 6) 29.56 ± 7.93 7.01 ± 1.17 5.76 ± 2.19 6.28 ± 2.71 80.95 ± 5.60
PND2 SS (n = 6) 38.21 ± 6.51 17.84 ± 3.28* 3.27 ± 2.14 6.89 ± 2.89 72.00 ± 5.65
PND2 FA (n = 6) 34.62 ± 4.39 8.27 ± 2.54 3.87 ± 1.88 8.99 ± 3.54 78.87 ± 5.98
PND21 SS (n = 6) 43.45 ± 4.59 12.84 ± 4.70 3.51 ± 2.12 4.38 ± 1.39 79.27 ± 8.62
PND21 FA (n = 6) 36.98 ± 6.33 10.27 ± 3.37 4.85 ± 2.66 5.21 ± 2.62 79.67 ± 9.31
Data are mean ± SE.
*Significant difference in corresponding data between FA and SS groups (p ≤ 0.05).Effects of prenatal and postnatal SS on lung function
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nerves in the airways. Increased NGF levels 
in BALF of infants after respiratory syncytial 
virus infection is associated with increased 
preprotachykinin gene expression in airways 
(Hu et al. 2002; Tortorolo et al. 2005), sup-
porting the possibility that NGF contributes 
to altered SP expression in early life. Thus, the 
effects of SS-induced NGF release on airway SP 
innervation during prenatal and early postnatal 
life, when the airways are under  going intense 
growth and development, might cause a change 
in airway responsiveness when exposed to SS 
much later in life.
Although we did not determine the exact 
mechanism of the enhanced MCh dose 
response by SS in the present study, results 
showed that the RL and Cdyn responses to MCh 
challenge between FA- and SS-exposed mice 
in the three different groups were not signifi-
cantly different before SS exposure on PND59 
but were significantly altered in SS- versus 
FA-exposed mice in the GD7 and PND2 expo-
sure groups after SS exposure on PND59. This 
alteration, in parallel with increased SP NFD in 
tracheal smooth muscle, indicates that SP may 
be involved. SP is a known bronchoconstrictor 
(Barnes et al. 1991), with direct actions on neu-
rokinin 1 receptors present on airway smooth 
muscle. However, previous studies also showed 
that SP enhances cholinergic responsiveness 
either through a direct effect on sensitivity of 
airway smooth muscle (Tanaka and Grunstein 
1990) or by enhancing acetylcholine release 
from parasympathetic nerve terminals (Larsen 
et al. 2004; Sekizawa et al. 1987).
The present study shows that an initial 
exposure to SS versus FA during the prenatal 
period was associated with significant changes 
in lung function and SP innervation in tra-
cheal smooth muscle after exposure to SS on 
PND59. But the physiologic mechanisms that 
cause these changes during in utero exposure 
remain unclear. ETS is composed of almost 
4,000 chemicals, including nicotine, carbon 
monoxide, cyanide, and ammonia. However, 
nicotine is probably the major component that 
crosses the placental barrier into the fetal cir-
culation. Sekhon et al. (2001) showed that 
fetal monkeys exposed to nicotine in the pre-
natal period had an increase in airway resis-
tance. Chen et al. (2005) found that animals 
treated with nicotine in utero had a reduction 
in alveolar surface area used for gas exchange. 
A recent study showed that nicotine, acting 
through the nicotinic acetyl  choline receptor, 
alters lung branching morphogenesis during 
the pre  natal period (Wongtrakool et al. 2007). 
These studies indicate that nicotine potentially 
alters normal lung growth during the prenatal 
period, which may subsequently affect pul-
monary function later in life. However, some 
other products from ETS exposure, such as 
4-aminobiphenyl or nitrosamine 4-methyl-
nitrosamino-3-pyridyl-1-butanone, can also 
cross the placenta, bind to fetal hemoglobin, 
and induce gene injury in the lung (Lackmann 
et al. 2000; Neri et al. 2006). It is also well 
known that the reduction of oxygen and the 
increase of carbon monoxide during ETS expo-
sure are detrimental to lung development dur-
ing the prenatal period (Buttigieg et al. 2008; 
California Environmental Protection Agency 
2005). Because of the complexity of ETS expo-
sure, we could not identify specific components 
involved in lung injury in our study.
In conclusion, exposure to SS during pre-
natal (maternal exposure) and early postnatal 
life was associated with changes in lung function 
later in life. These findings suggest that prenatal 
and early postnatal life are periods of suscep-
tibility to inhaled SS that are associated with 
enhanced SP innervation of the airways and 
higher levels of NGF in the lung. Interestingly, 
we did not observe these responses when SS 
exposure occurred in later post  natal life (near 
puberty in mice), suggesting that the period of 
susceptibility is confined to the prenatal and 
early postnatal periods in mice.
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